Co-Authors
This is a "connection" page, showing publications co-authored by Xuping Xie and Camila Fontes-Garfias.
Connection Strength
1.517
-
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2021 Jun 21; 12(1):3984.
Score: 0.238
-
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med. 2021 04; 27(4):620-621.
Score: 0.232
-
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test. Diagn Microbiol Infect Dis. 2021 Feb; 99(2):115248.
Score: 0.227
-
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2020 10 15; 11(1):5214.
Score: 0.227
-
Functional Analysis of Glycosylation of Zika Virus Envelope Protein. Cell Rep. 2017 Oct 31; 21(5):1180-1190.
Score: 0.185
-
Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 Jul; 595(7865):E1.
Score: 0.060
-
Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2021 Jun 22; 12(1):4000.
Score: 0.060
-
BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants. N Engl J Med. 2021 07 29; 385(5):472-474.
Score: 0.059
-
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization. NPJ Vaccines. 2021 Mar 25; 6(1):44.
Score: 0.059
-
Neutralizing Activity of BNT162b2-Elicited Serum. N Engl J Med. 2021 04 15; 384(15):1466-1468.
Score: 0.058
-
Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 04; 592(7852):116-121.
Score: 0.057
-
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2020 08 13; 11(1):4059.
Score: 0.056